Status:
COMPLETED
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC
Lead Sponsor:
University of Pittsburgh
Conditions:
Gram Negative Organism
Eligibility:
All Genders
Brief Summary
The isolate samples will be collected over a period of one year once IRB approval has been obtained. These isolates were collected as part of the patient's clinical care and once all clinical testing ...
Detailed Description
The study will collect two hundred pseudomonas and 20 acinetobacter baumanti consecutive bacterial isolates from microbiology. These isolates are collected as part of the patient's clinical care and a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Samples" for the purpose of this study are Gram negative bacteria in a Petri dish of growth media.
Exclusion
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00443885
Start Date
February 1 2007
End Date
January 1 2017
Last Update
June 12 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213
2
UPMC
Pittsburgh, Pennsylvania, United States, 15213